Description
Composition
Each prefilled syringe of HEPARINOX® 40 mg contains: Enoxaparin sodium 40 mg (equivalent to 4,000 IU), water for injection s.q. 0.4 ml
Each prefilled syringe of HEPARINOX® 60 mg contains: Enoxaparin sodium 60 mg (equivalent to 6,000 IU), water for injection s.q. 0.6 ml
Each prefilled syringe of HEPARINOX® 80 mg contains: Enoxaparin sodium 80 mg (equivalent to 8,000 IU), water for injection s.q. 0.8 ml
Therapeutic Action
Antithrombotic agent. Low molecular weight heparin.
Indications
– Prophylaxis of thromboembolic venous disease, especially that which could be related to general or orthopedic surgery.
– Prophylaxis of venous thromboembolism in bedridden patients due to acute diseases such as heart failure, respiratory failure, serious infections or rheumatic diseases.
– Treatment of deep venous thrombosis, with or without pulmonary embolism.
– Prevention of thrombus formation in the extracorporeal circulation during hemodialysis.
– Treatment of unstable angina and non-Q myocardial infarction with concomitant administration of aspirin.
– Treatment of Acute Myocardial Infarction with ST segment elevation (STEMI, ST-Segment Elevation Myocardial Infarction), including patients to be managed medically or with subsequent Coronary Percutaneous Intervention.
Presentations
HEPARINOX® 40 mg / 0.4 ml: 10 prefilled syringes with 0.4 ml solution
HEPARINOX® 60 mg / 0.6 ml: 10 prefilled syringes with 0.6 ml solution
HEPARINOX® 80 mg / 0.8 ml: 10 prefilled syringes with 0.8 ml of solution
